Delivery Order SPE2DR25D3016-SPE2DR26FG1DP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,004.33 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitive award, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price transaction with no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- The Defense Logistics Agency awarded a delivery order valued at $37,515.43 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This firm fixed-price contract, awarded on June 6, 2025, with an ultimate completion date of June 9, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the company's corporate headquarters in...
- The Defense Logistics Agency awarded a $14,891.23 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical product requisition under the agency's medical supply procurement operations. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $22,859.06 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of May 28, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $30,496.07 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed price contract with an ultimate completion date of August 8, 2025, and represents a competitively awarded, non-set-aside procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,133.30 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by October 29, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $1,349.49. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement with a completion date of July 31, 2025. The delivery order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and a major pharmaceutical distribution hub...
- The Defense Logistics Agency awarded a delivery order valued at $7,450.02 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure with an ultimate completion date of August 18, 2025. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $14,560.32 for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, awarded on November 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters operations. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,804.40 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract is a firm fixed price delivery order issued on July 18, 2025, with an ultimate completion date of July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. No set-aside designation was used for...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG1DPDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $37,827.70 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed price contract involves no set-aside designation and carries an ultimate completion date of November 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical distributor and healthcare solutions provider. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to meet the Department of Defense's pharmaceutical procurement requirements across multiple therapeutic domains on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.8k | 11/17/25 |